You Are Browsing ‘Health’ Category

Ardelyx Inc (NASDAQ:ARDX) has decided to buy out of its partnership with AstraZeneca plc (ADR) (NYSE:AZN) after their joint efforts in its lead drug, didn’t go so well. Ardelyx will give AstraZeneca an initial $15 million and $10 million in form of research and development costs. AtraZeneca entered into…

Decades after Earl Bakken came up with the first pacemaker in the 60s, Medtronic PLC (NYSE:MDT) has introduced a considerably smaller pacemaker that could…

American biopharmaceutical giant company, Gilead Sciences, Inc. (NASDAQ:GILD) reported it will invest an additional capital of $100 million to expand its…

Medtronic PLC (NYSE:MDT) is increasing the number of affordable medical services that it offers in the Chinese market as well as potentially lucrative…

An analyst from a Deutsche Bank stated that Pharmaceutical company Pfizer Inc. (NYSE:PFE), would reap a lot of benefits if it were to acquire its rival…

Johnson & Johnson (NYSE:JNJ) has started casting out its investment net over various potentially successful drug treatments for popular conditions…

German health care company Merck & Co., Inc. (NYSE:MRK) has high hopes on its mission to successfully develop its anti-PDL1 immuno- oncology treatment…

Steve Boyd’s Hedge fund Armistice Capital had demanded the Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to dump its CEO and find a new buyer quickly….

PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI) has announced that the appointment of Todd Wider as the MD of the Board of Directors. The focus of this…

La Jolla Pharmaceutical Company (NASDAQ:LJPC) has brought to halt, the clinical trials of the GCS-100 and the LJPA-1010 drugs due to the strict regulations…

SPYR banner1